974 related articles for article (PubMed ID: 33251044)
1. Immune-Related lncRNA to Construct Novel Signature and Predict the Immune Landscape of Human Hepatocellular Carcinoma.
Hong W; Liang L; Gu Y; Qi Z; Qiu H; Yang X; Zeng W; Ma L; Xie J
Mol Ther Nucleic Acids; 2020 Dec; 22():937-947. PubMed ID: 33251044
[TBL] [Abstract][Full Text] [Related]
2. Construction of a novel immune-related lncRNA signature and its potential to predict the immune status of patients with hepatocellular carcinoma.
Deng M; Lin JB; Zhao RC; Li SH; Lin WP; Zou JW; Wei W; Guo RP
BMC Cancer; 2021 Dec; 21(1):1347. PubMed ID: 34923955
[TBL] [Abstract][Full Text] [Related]
3. Identification and Validation of a Novel Immune-Related lncRNA Signature for Bladder Cancer.
Hua S; Xie Z; Wang W; Wan Z; Chen M; Zhao S; Jiang J
Front Oncol; 2021; 11():704946. PubMed ID: 34322391
[TBL] [Abstract][Full Text] [Related]
4. Construction of a Novel Lung Adenocarcinoma Immune-Related lncRNA Pair Signature.
Qi X; Chen G; Chen Z; Li J; Chen W; Lin J; Lin L
Int J Gen Med; 2021; 14():4279-4289. PubMed ID: 34421308
[TBL] [Abstract][Full Text] [Related]
5. Using Immune-Related Long Non-coding Ribonucleic Acids to Develop a Novel Prognosis Signature and Predict the Immune Landscape of Colon Cancer.
Wang X; Chen K; Wang Z; Xu Y; Dai L; Bai T; Chen B; Yang W; Chen W
Front Cell Dev Biol; 2021; 9():750709. PubMed ID: 34660608
[No Abstract] [Full Text] [Related]
6. Immune-Related lncRNA Signature for Predicting the Immune Landscape of Head and Neck Squamous Cell Carcinoma.
Yin J; Li X; Lv C; He X; Luo X; Li S; Hu W
Front Mol Biosci; 2021; 8():689224. PubMed ID: 34327215
[No Abstract] [Full Text] [Related]
7. Identification of Immune-Related lncRNA Pairs and Construction and Validation of a New Prognostic Signature of Colon Cancer.
Xu M; Li Q; Zhang J; Xie H
Can J Gastroenterol Hepatol; 2022; 2022():5827544. PubMed ID: 35399646
[TBL] [Abstract][Full Text] [Related]
8. Construction of a Novel Immune-Related lncRNA Pair Signature with Prognostic Significance for Kidney Clear Cell Renal Cell Carcinoma.
Sun JX; Xia QD; Liu CQ; Xu JZ; Xun Y; Lu JL; Hu J; Wang SG
Dis Markers; 2021; 2021():8800358. PubMed ID: 34512816
[TBL] [Abstract][Full Text] [Related]
9. Novel Prognosis and Therapeutic Response Model of Immune-Related lncRNA Pairs in Clear Cell Renal Cell Carcinoma.
Wang G; Liu P; Li J; Jin K; Zheng X; Xie L
Vaccines (Basel); 2022 Jul; 10(7):. PubMed ID: 35891325
[TBL] [Abstract][Full Text] [Related]
10. Characterization of Immune-Related Long Non-coding RNAs to Construct a Novel Signature and Predict the Prognosis and Immune Landscape of Soft Tissue Sarcoma.
Lin Z; Pang K; Li H; Zhang X; Wan J; Zheng T; Liu T; Peng W
Front Cell Dev Biol; 2021; 9():709241. PubMed ID: 34631703
[No Abstract] [Full Text] [Related]
11. Predicting the immune landscape of invasive breast carcinoma based on the novel signature of immune-related lncRNA.
Shen S; Chen X; Hu X; Huo J; Luo L; Zhou X
Cancer Med; 2021 Sep; 10(18):6561-6575. PubMed ID: 34378851
[TBL] [Abstract][Full Text] [Related]
12. Immune-related lncRNA pairs as novel signature to predict prognosis and immune landscape in melanoma patients.
Li Z; Wei J; Zheng H; Gan X; Song M; Zhang Y; Jin Y
Medicine (Baltimore); 2022 Jan; 101(1):e28531. PubMed ID: 35029920
[TBL] [Abstract][Full Text] [Related]
13. A novel immune-related lncRNA signature predicts the prognosis and immune landscape in ccRCC.
Dai L; Pan D; Jin J; Lv W
Aging (Albany NY); 2024 Mar; 16(6):5149-5162. PubMed ID: 38484738
[TBL] [Abstract][Full Text] [Related]
14. Construction of a new immune-related lncRNA model and prediction of treatment and survival prognosis of human colon cancer.
Liu S; Peng X; Wu X; Bu F; Yu Z; Zhu J; Luo C; Zhang W; Liu J; Huang J
World J Surg Oncol; 2022 Mar; 20(1):71. PubMed ID: 35249533
[TBL] [Abstract][Full Text] [Related]
15. A Novel Signature Constructed by Immune-Related LncRNA Predicts the Immune Landscape of Colorectal Cancer.
Sun M; Zhang T; Wang Y; Huang W; Xia L
Front Genet; 2021; 12():695130. PubMed ID: 34434220
[TBL] [Abstract][Full Text] [Related]
16. A novel immune-related long non-coding RNA signature improves the prognosis prediction in the context of head and neck squamous cell carcinoma.
Chen L; Cai Z; Lyu K; Cai Z; Lei W
Bioengineered; 2021 Dec; 12(1):2311-2325. PubMed ID: 34167440
[TBL] [Abstract][Full Text] [Related]
17. Predicting the Survival and Immune Landscape of Colorectal Cancer Patients Using an Immune-Related lncRNA Pair Model.
Ma C; Zhang X; Zhao X; Zhang N; Zhou S; Zhang Y; Li P
Front Genet; 2021; 12():690530. PubMed ID: 34552614
[TBL] [Abstract][Full Text] [Related]
18. Immune-Related lncRNA Pairs as Prognostic Signature and Immune-Landscape Predictor in Lung Adenocarcinoma.
Yin Z; Zhou M; Liao T; Xu J; Fan J; Deng J; Jin Y
Front Oncol; 2021; 11():673567. PubMed ID: 35083132
[TBL] [Abstract][Full Text] [Related]
19. Immune-Related lncRNAs Pairs to Construct a Novel Signature for Predicting Prognosis in Gastric Cancer.
Bao T; Wang Z; Xu J
Front Surg; 2022; 9():807778. PubMed ID: 35402492
[TBL] [Abstract][Full Text] [Related]
20. A novel signature to predict thyroid cancer prognosis and immune landscape using immune-related LncRNA pairs.
Song B; Tian L; Zhang F; Lin Z; Gong B; Liu T; Teng W
BMC Med Genomics; 2022 Aug; 15(1):183. PubMed ID: 35996170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
